| dc.contributor.author | Kissin, Igor | |
| dc.date.accessioned | 2013-04-26T17:21:49Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | Kissin, Igor. 2013. An early indicator of drug success: top journal selectivity index. Drug Design, Development and Therapy 7: 93-98. | en_US |
| dc.identifier.issn | 1177-8881 | en_US |
| dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:10589777 | |
| dc.description.abstract | The Top Journal Selectivity Index (TJSI) is a scientometric index reflecting the potential importance of a new drug. It represents the ratio of the number of all types of articles on a particular drug in the top 20 journals relative to the number of articles in all (>5,000) biomedical journals covered by Medline over the 5 years since the drug’s introduction. The TJSI can be an indicator of a drug’s potential for sustained use: a higher score increases the probability of continuing success. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | Dove Medical Press | en_US |
| dc.relation.isversionof | doi:10.2147/DDDT.S37324 | en_US |
| dc.relation.hasversion | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575128/pdf/ | en_US |
| dash.license | LAA | |
| dc.subject | bibliometrics | en_US |
| dc.subject | ‘me-too’ drugs | en_US |
| dc.subject | pharmaceutical market | en_US |
| dc.subject | scientometrics | en_US |
| dc.title | An early indicator of drug success: Top Journal Selectivity Index | en_US |
| dc.type | Journal Article | en_US |
| dc.description.version | Version of Record | en_US |
| dc.relation.journal | Drug Design, Development and Therapy | en_US |
| dash.depositing.author | Kissin, Igor | |
| dc.date.available | 2013-04-26T17:21:49Z | |
| dc.identifier.doi | 10.2147/DDDT.S37324 | * |
| dash.contributor.affiliated | Kissin, Igor | |
